News
MORRISVILLE, N.C., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2023 Health Trends ...
Syneos Health Inc. SYNH recently extended its strategic partnership with Medable — the technology platform provider for patient-centered clinical trials. The extended partnership is a part of ...
May 10 (Reuters) - An investment consortium, comprising of Elliott Investment Management, Patient Square Capital and Veritas Capital, has agreed to take Syneos Health Inc (SYNH.O), opens new tab ...
Feb 27 (Reuters) - Syneos Health Inc (SYNH.O), opens new tab is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a ...
MORRISVILLE – Syneos Health is now a private company, having wrapped up its deal valued at some $7 billion with private equity partners Elliott Investment Management L.P., Patient Square ...
Syneos Health, a leading biopharmaceutical contract research organization, agreed to be acquired for $7.1 billion by a group of private equity firms. Elliott Investment Management, Patient Square ...
The multi-billion dollar deal to acquire Syneos Health comes amid an earnings slump for the company as the life sciences industry faces mounting headwinds. Report: $5B Triangle firm eyes sale amid ...
An awful day for the stock market turned into a terrible one for shares of Syneos Health (SYNH), which fell 13.7%. This slide was driven by an operational update provided during an investor ...
Syneos Health merits a narrow moat in the industry. Not all of the Q3 results look bad - key figures were improved, commercial solutions business revenue growth was strong, and there's still $350 ...
Syneos Health is a global provider of end-to-end biopharmaceutical outsourcing solutions. The Company operates through two segments, Clinical Solutions and Commercial Solutions, and provides a ...
Triangle's big CROs ride double-digit revenue growth into 2022 Syneos buys RTP data science firm in 'critical' move for CRO's future Syneos buys RTP data science firm in 'critical' move for CRO's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results